1Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Japan
2Radiology, Fujita Health University Okazaki Medical Center, Okazaki, Japan
3Radiology, Fujita Health University Bantane Hospital, Nagoya, Japan
4Canon Medical Systems Corporation, Otawara-shi, Japan
5Joint Research Laboratory of Advanced Medical Imaging & Artificial Intelligence, Fujita Health University School of Medicine, Toyoake, Japan
6Diagnostic Radiology, Shizuoka Cancer Center, Sunto-gun, Japan
Presenting Author: Yoshiharu Ohno
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Erasmus JJ, Rohren E, Swisher SG. Prognosis and reevaluation of lung cancer by positron emission tomography imaging. Proc Am Thorac Soc. 2009 Apr 15;6(2):171-179.
2. Mirpour S, Mhlanga JC, Logeswaran P, Russo G, Mercier G, Subramaniam RM. The role of PET/CT in the management of cervical cancer. AJR Am J Roentgenol. 2013 Aug;201(2):W192-205.
3. Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J. Imaging for Staging and Response Assessment in Lymphoma. Radiology. 2015 Aug;276(2):323-338.
4. Van de Wiele C, Juanito G, Vander BK, et al. Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients. Semin Nucl Med. 2021 Nov;51(6):544-553.
5. Qu X, Huang X, Yan W, Wu L, Dai K. A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Eur J Radiol. 2012 May;81(5):1007-1015.
6. Spick C, Herrmann K, Czernin J. 18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients. J Nucl Med. 2016 Mar;57(3):420-430.
7. Ohno Y, Yui M, Aoyagi K, et al. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging. AJR Am J Roentgenol. 2019 Feb;212(2):311-319.
8. Ohno Y, Yoshikawa T, Takenaka D, et al. Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI. AJR Am J Roentgenol. 2022 May;218(5):899-908.
9. Ohno Y, Koyama H, Yoshikawa T, et al. Pulmonary high-resolution ultrashort TE MR imaging: Comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma diseases. J Magn Reson Imaging. 2016 Feb;43(2):512-32.
10. Ohno Y, Koyama H, Yoshikawa T, et al. Standard-, Reduced-, and No-Dose Thin-Section Radiologic Examinations: Comparison of Capability for Nodule Detection and Nodule Type Assessment in Patients Suspected of Having Pulmonary Nodules. Radiology. 2017 Aug;284(2):562-573.
11. Ohno Y, Takenaka D, Yoshikawa T, et al. Efficacy of Ultrashort Echo Time Pulmonary MRI for Lung Nodule Detection and Lung-RADS Classification. Radiology. 2022 Mar;302(3):697-706.
12. Ohno Y, Yui M, Yamamoto K, et al. Pulmonary MRI with ultra-short TE using single- and dual-echo methods: comparison of capability for quantitative differentiation of non- or minimally invasive adenocarcinomas from other lung cancers with that of standard-dose thin-section CT. Eur Radiol. 2024 Feb;34(2):1065-1076.